Search Results - "Lalkota, Bhanu Prakash"

Prospective Analysis of Patients with Metastatic Breast Cancer receiving Eribulin Mesylate as Second or More Lines of Chemotherapy: An Indian Experience by Srinivasa, BJ, Lalkota, Bhanu Prakash, Badarke, Girish, Hazarika, Diganta, Mohammad, Nasiruddin, Sapkota, Sulav, Khanderia, Mansi, Tousif, D, Rao, Raghavendra, Ram, Amritanshu, Patil, Shekar, Naik, Radheshyam

“…Background: Eribulin mesylate is a non-taxane microtubule inhibitor which can be used after anthracycline and taxane treatment in patients with metastatic…”
Get full text

Translational relevance of androgen receptor immunohistochemistry scoring systems for data harmonization in triple negative breast cancer (TNBC) by Mufti, Suhail Sayeed, Lalkota, Bhanu Prakash, BN, Tejaswini, Varayathu, Hrishi, Sarathy, Vinu, Puii, Lalnun, Sangi, Lalram, Thomas, Beulah Elsa, Hazarika, Diganta, Thungappa, Satheesh Chiradoni, Bj, Sriniivas, Patil, Shekar, Naik, Radheshyam, Ajaikumar, Basavalinga Sadasivaiah

“…Abstract only 1078 Background: Androgen receptor (AR) expressing triple negative breast cancer (TNBC) is a sub-set of TNBC with an evolving prognostic and…”
Get full text

Outcome of locally advanced carcinoma of oesophagus: A single institution experience by S, Thianeshwaran, Bj, Sriniivas, Sanghavi, Niyati Prakash, Sarathy, Vinu, Lalkota, Bhanu Prakash, PK, Kiran, Byas, Nitin, Shah, Mansi, N, Madhusudhan, Varayathu, Hrishi, Puii, Lalnun, Hazarika, Diganta, Mufti, Suhail Sayeed, Ajaikumar, Basavalinga Sadasivaiah, Radheshyam, Naik

“…Abstract only e16507 Background: Oesophageal cancer is the twelfth most common cancer worldwide and seventh leading cause of cancer related death. Neoadjuvant…”
Get full text

The role of p53 and ki67 in predicting clinical outcome in breast cancer patients by Lalkota, Bhanu Prakash, Srinivasa, B J, Swamy, Mani V, Hazarika, Diganta, Jeet, B M, Jyothi, K, Ghosh, Mithua, Sayeed, Suhail M, Nasiruddin, Mohammad, Naik, Radheshyam

“…">ki67 may be used as a proliferative index in addition to estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2…”
Get full text

Recurrent squamous cell carcinoma of the skin treated with immunotherapy by Srinivasa, B, Sridhar, P, Lalkota, Bhanu, Tsikai, Nomsa, Niyati, P, Shah, Mansi, Anuradha, S, Roopesh, R, Ramaswamy, Veena, Naik, Radheshyam, Ajaikumar, B

“…Squamous cell carcinoma (SCC) has a good prognosis, while metastatic tumors have aggressive behavior. Immunotherapy has become a standard line of treatment in…”
Get full text

Reversible hypopigmentation with pazopanib by Srinivasa, B, Lalkota, Bhanu, Chindar, Pramod, Naik, Radheshyam

“…Tablet Pazopanib known to cause Hypo pigmentation and Hyperpigmentation as per various literature reports. We report here a case of reversible hypopigmentation…”
Get full text

Recurrent squamous cell carcinoma of the skin treated with immunotherapy by Srinivasa, B J, Sridhar, P S, Lalkota, Bhanu Prakash, Tsikai, Nomsa, Niyati, P S, Shah, Mansi, Anuradha, S, Roopesh, R, Ramaswamy, Veena, Naik, Radheshyam, Ajaikumar, B S

Get full text